AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: Zaidi Isham Ismail
MALAYSIA'S first full-fledged biopharmaceutical company Inno Biologics Sdn Bhd is all set to become one of the world's top pharmaceutical players now that all the necessary infrastucture has been put in place.
It is close to clinching up to five contracts worth a combined US$25 million (US$1 = RM3.48) by year-end, said chief executive officer Datuk Dr Mohd Nazlee Kamal.
Three of the contracts are from the US worth US$15 million, while the other two are from Europe valued at US$10 million.
Mohd Nazlee said since the establishment of its biopharmaceutical complex in September 2006, Inno Biologics has been busy making sure …